Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 759, pseudogene (RN7SL759P) is a human pseudogene related to the 7SL RNA, a non-coding RNA that normally functions as the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in targeting secretory proteins to the endoplasmic reticulum[1][3][4]. However, RN7SL759P itself is a **pseudogene**—a genomic sequence similar to the parent 7SL RNA gene but typically nonfunctional: it does not encode a functional RNA or protein, and is not involved in canonical SRP-mediated mechanisms[1][5][6]. The **majority of 7SL-like sequences in human DNA are pseudogenes**, formed by the reverse transfer of 7SL RNA into the genome[5][6]. Pseudogenes like RN7SL759P are not known to serve as therapeutic targets, biological markers, or drug interaction sites, nor are they associated with specific biological or disease roles ascribed to their functional counterparts[1][5]. **Explanation and evidence:** - The gene is a *pseudogene*, not an active gene or protein product. It is not a receptor, enzyme, transporter, or transcription factor[1][5]. - Pseudogenes generally do not produce active RNA or protein and do not serve as direct drug targets, nor are they typically implicated in major disease processes or therapeutic mechanisms[1][5][6]. - The canonical function applies to *functional* 7SL RNA, not its pseudogenes[3][4]. - There is nothing misspelled or incorrect in the query, provided the intent is to refer to this specific *pseudogene*. **Summary:** RN7SL759P is a 7SL RNA pseudogene, not a therapeutic or biological target, and does not play a functional role in cellular physiology or drug action[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 759, pseudogene (RN7SL759P).